[Fibrinolytic system in patients with nephrotic syndrome].
D000293:Adolescent; D000328:Adult; D005176:Factor XIII / Q000032:analysis; D005338:Fibrin Fibrinogen Degradation Products / Q000097:blood; D005340:Fibrinogen / Q000032:analysis; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D005342:Fibrinolysis; D006801:Humans; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000097:blood*; D010958:Plasminogen / Q000032:analysis; D010960:Plasminogen Activators / Q000037:antagonists & inhibitors / Q000097:blood; D015849:Plasminogen Inactivators; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors / Q000097:blood
D005338:Fibrin Fibrinogen Degradation Products; D015849:Plasminogen Inactivators; D005340:Fibrinogen; D010958:Plasminogen; D005176:Factor XIII; D010960:Plasminogen Activators; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator
Sostoianie fibrinoliticheskoĭ sistemy u bol'nykh s nefroticheskim sindromom